DDOST is associated with tumor immunosuppressive microenvironment in cervical cancer

Jie Mei1, Liuliu Pan1, Min Huang1

  • 1Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325027, China.

Discover Oncology
|March 9, 2024
PubMed

Insights

DDOST is upregulated in cervical cancer, correlating with poor prognosis and reduced immune cell infiltration. This suggests DDOST as a potential biomarker and therapeutic target for cervical cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background:

  • DDOST (Dolichyl-diphosphooligosaccharide-protein glycosyltransferase subunit 1) is implicated in cancer development.
  • Its specific role in cervical tumorigenesis remains unexplored.

Purpose of the Study:

  • To investigate the function of DDOST in cervical cancer.
  • To analyze the association of DDOST with prognosis, genetic mutations, promoter methylation, immune cell infiltration, and drug sensitivity.

Main Methods:

  • Bioinformatics techniques were employed.
  • Analysis included Cox regression and immune infiltration analysis.

Main Results:

  • DDOST was significantly upregulated in various tumors, including cervical cancer, and linked to poor prognosis.
  • High DDOST expression correlated with reduced CD8 T cells and NK cells.
  • Drug sensitivity was negatively associated with DDOST expression.

Conclusions:

  • DDOST plays a crucial role in the tumor microenvironment and immune regulation in cervical cancer.
  • DDOST represents a potential prognostic biomarker and therapeutic target for cervical cancer.

Related Concept Videos